Chemical Features Important for Activity in a Class of Inhibitors Targeting the Wip1 Flap Subdomain.

ChemMedChem
Harichandra D TagadDaniel H Appella

Abstract

The wild-type p53 induced phosphatase 1, Wip1 (PP2Cδ), is a protein phosphatase 2C (PP2C) family serine/threonine phosphatase that negatively regulates the function of the tumor suppressor p53 and several of its positive regulators such as ATM, Chk1, Chk2, Mdm2, and p38 MAPK. Wip1 dephosphorylates and inactivates its protein targets, which are critical for cellular stress responses. Additionally, Wip1 is frequently amplified and overexpressed in several human cancer types. Because of its negative role in regulating the function of tumor suppressor proteins, Wip1 has been identified as a potential therapeutic target in various types of cancers. Based on a recently reported Wip1 inhibitor (G-1), we performed an extensive structure-activity relationship (SAR) analysis. This led us to interesting findings in SAR trends and to the discovery of new chemical analogues with good specificity and bioavailability.

References

Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·M FiscellaE Appella
May 5, 2005·Genes & Development·Xiongbin LuLawrence A Donehower
Nov 29, 2005·Cell Death and Differentiation·H FujimotoY Minami
Sep 5, 2006·Molecular Cell·Sathyavageeswaran ShreeramDmitry V Bulavin
Oct 13, 2007·Journal of Neuro-oncology·Robert C CastellinoJohn Y H Kim
Feb 13, 2008·Cancer Metastasis Reviews·Xiongbin LuLawrence A Donehower
Mar 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S P TanJorge S Reis-Filho
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rachael NatrajanJorge S Reis-Filho
May 13, 2010·Cancer Research·Hyukjin ChaAlbert J Fornace
Jan 7, 2014·Nature Chemical Biology·Aidan G GilmartinRakesh Kumar
Dec 31, 2015·Apoptosis : an International Journal on Programmed Cell Death·Bo WuKai-Xing Ai
Feb 18, 2016·Oncotarget·Anastasia R GoloudinaOleg N Demidov
Apr 26, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Soňa PecháčkováLibor Macurek

❮ Previous
Next ❯

Citations

Jul 11, 2020·Pharmacology & Therapeutics·Rui KamadaKazuyasu Sakaguchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Related Papers

Trends in Biochemical Sciences
Xavier Le Guezennec, Dmitry Bulavin
Frontiers in Bioscience (Landmark Edition)
Julie LoweAlbert J Fornace
Current Topics in Medicinal Chemistry
Margarida EspadinhaMaria M M Santos
© 2022 Meta ULC. All rights reserved